277 related articles for article (PubMed ID: 26598579)
1. Classic Studies on the Interaction of Cocaine and the Dopamine Transporter.
Verma V
Clin Psychopharmacol Neurosci; 2015 Dec; 13(3):227-38. PubMed ID: 26598579
[TBL] [Abstract][Full Text] [Related]
2. [The dopamine transporter: characterization and physiopathologic implications].
Thibaut F; Vaugeois JM; Petit M
Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
[TBL] [Abstract][Full Text] [Related]
3. Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine.
Siciliano CA; Fordahl SC; Jones SR
J Neurosci; 2016 Jul; 36(30):7807-16. PubMed ID: 27466327
[TBL] [Abstract][Full Text] [Related]
4. Effects of cocaine and repeated cocaine followed by withdrawal. Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition.
Meiergerd SM; McElvain JS; Schenk JO
Biochem Pharmacol; 1994 Apr; 47(9):1627-34. PubMed ID: 8185677
[TBL] [Abstract][Full Text] [Related]
5. One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter.
Ben-Shahar O; Moscarello JM; Ettenberg A
Brain Res; 2006 Jun; 1095(1):148-53. PubMed ID: 16712814
[TBL] [Abstract][Full Text] [Related]
6. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.
Letchworth SR; Nader MA; Smith HR; Friedman DP; Porrino LJ
J Neurosci; 2001 Apr; 21(8):2799-807. PubMed ID: 11306632
[TBL] [Abstract][Full Text] [Related]
7. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
Farfel GM; Kleven MS; Woolverton WL; Seiden LS; Perry BD
Brain Res; 1992 Apr; 578(1-2):235-43. PubMed ID: 1380862
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
Claye LH; Akunne HC; Davis MD; DeMattos S; Soliman KF
Mol Neurobiol; 1995; 11(1-3):55-66. PubMed ID: 8561968
[TBL] [Abstract][Full Text] [Related]
9. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
Kahlig KM; Galli A
Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
[TBL] [Abstract][Full Text] [Related]
11. Cocaine self-administration in dopamine-transporter knockout mice.
Rocha BA; Fumagalli F; Gainetdinov RR; Jones SR; Ator R; Giros B; Miller GW; Caron MG
Nat Neurosci; 1998 Jun; 1(2):132-7. PubMed ID: 10195128
[TBL] [Abstract][Full Text] [Related]
12. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
[TBL] [Abstract][Full Text] [Related]
13. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
Seger D
Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
[TBL] [Abstract][Full Text] [Related]
14. Kinetic evaluation of the commonality between the site(s) of action of cocaine and some other structurally similar and dissimilar inhibitors of the striatal transporter for dopamine.
Meiergerd SM; Schenk JO
J Neurochem; 1994 Nov; 63(5):1683-92. PubMed ID: 7931324
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter development in postnatal rat striatum: an autoradiographic study with [3H]WIN 35,428.
Coulter CL; Happe HK; Murrin LC
Brain Res Dev Brain Res; 1997 Dec; 104(1-2):55-62. PubMed ID: 9466707
[TBL] [Abstract][Full Text] [Related]
16. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter.
Rothman RB; Grieg N; Kim A; De Costa BR; Rice KC; Carroll FI; Pert A
Pharmacol Biochem Behav; 1992 Dec; 43(4):1135-42. PubMed ID: 1475296
[TBL] [Abstract][Full Text] [Related]
17. 2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitors.
Sakamuri S; Enyedy IJ; Zaman WA; Tella SR; Kozikowski AP; Flippen-Anderson JL; Farkas T; Johnson KM; Wang S
Bioorg Med Chem; 2003 Mar; 11(6):1123-36. PubMed ID: 12614900
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
[TBL] [Abstract][Full Text] [Related]
19. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides.
Silvia CP; Jaber M; King GR; Ellinwood EH; Caron MG
Neuroscience; 1997 Feb; 76(3):737-47. PubMed ID: 9135047
[TBL] [Abstract][Full Text] [Related]
20. Striatal dopaminergic abnormalities in human cocaine users.
Little KY; Zhang L; Desmond T; Frey KA; Dalack GW; Cassin BJ
Am J Psychiatry; 1999 Feb; 156(2):238-45. PubMed ID: 9989560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
